For millions of low-income Americans, Medicaid isn’t just health insurance-it’s the only thing standing between them and skipping doses because they can’t afford their meds. And the reason so many can actually fill their prescriptions? Generics. They’re not just cheaper alternatives. They’re the backbone of Medicaid’s ability to keep care affordable.
In 2023, 91% of all prescriptions filled through Medicaid were for generic drugs. That’s not a coincidence. It’s by design. These drugs work the same as brand-name versions, have the same active ingredients, and are held to the same FDA standards. But here’s the kicker: while generics made up over 9 out of every 10 prescriptions, they accounted for less than 18% of total Medicaid drug spending. That’s because they cost a fraction of the price.
How Much Do Generics Actually Save?
The numbers don’t lie. In 2023, the average copay for a generic drug under Medicaid was $6.16. For a brand-name drug? $56.12. That’s nearly nine times more. For someone living paycheck to paycheck, that difference isn’t just money-it’s whether they take their blood pressure pills, their insulin, or their asthma inhaler.
And it’s not just the patient paying less. Medicaid itself saves billions. Thanks to the Medicaid Drug Rebate Program, drug manufacturers must give states a cut of the price just to get their drugs covered. In 2023, those rebates cut Medicaid’s gross drug spending by over half-$53.7 billion saved. For every dollar spent on prescriptions, nearly 51 cents went straight back into the system because of rebates. That’s why Medicaid gets the lowest net prices of any federal health program-even lower than the Department of Veterans Affairs.
Why Generics Are So Cheap-And Why That Matters
Generic drugs don’t need to repeat expensive clinical trials. Once a brand-name drug’s patent expires, other companies can make the same medicine. That competition drives prices down. In 2022, generics saved the U.S. healthcare system $408 billion. Since 2009, that total is now over $2.9 trillion.
But here’s what most people don’t realize: Medicaid doesn’t just rely on generics. It actively pushes them. Most states automatically substitute a generic when a brand-name drug is prescribed-unless the doctor says otherwise. That means patients get the same medicine, often without even knowing they switched. And because generics are so cheap, 93% of them cost less than $20 at the pharmacy counter. Compare that to brand-name drugs, where only 59% fall under that threshold.
Where the System Still Falls Short
Even with all these savings, the system isn’t perfect. Some patients still struggle. The Georgetown Center for Children and Families found that even when generic drug prices drop, Medicaid copays don’t always follow. Some states have fixed copay tiers that haven’t changed in years. A patient might pay $10 for a generic that now costs $3 at the pharmacy. That’s money wasted.
Then there’s the paperwork. One Reddit user, 'MedicaidMom2023', shared how her daughter’s asthma inhaler switched to a generic-cutting her copay from $25 to $3. But getting approval took three weeks and five phone calls. Prior authorization rules, meant to prevent overuse, often delay care. About 15-20% of all Medicaid prescriptions get held up by these rules, even for generics.
And then there are the middlemen. Pharmacy Benefit Managers (PBMs)-the companies that negotiate drug prices between insurers and pharmacies-take a cut. An Ohio audit in 2025 found PBMs collected 31% of the cost on $208 million worth of generic drugs in just one year. That’s $64 million in fees. That money doesn’t go to patients. It doesn’t go to pharmacies. It goes to corporate profits.
Specialty Drugs Are Changing the Game
Here’s the twist: while generics dominate in volume, they don’t dominate in cost. That’s because of specialty drugs. These are high-priced medications for complex conditions like cancer, MS, or rare diseases. In 2021, less than 2% of Medicaid prescriptions were for these drugs-but they made up more than half of total spending.
That’s why Medicaid’s net drug spending jumped from $30 billion in 2017 to $60 billion in 2024. Generics are still saving money. But the rising cost of a few very expensive drugs is eating into those savings. That’s why the Centers for Medicare & Medicaid Services (CMS) launched the GENEROUS Model in 2024. It’s a pilot program to redesign how Medicaid handles drug formularies, push for better pricing, and reduce waste.
What This Means for Patients
If you’re on Medicaid, here’s what you need to know:
- Always ask if a generic version is available. Even if your doctor prescribes a brand, pharmacists can switch it unless told not to.
- Know your state’s copay rules. Some states cap generic copays at $3 or $5. Others let them rise with inflation.
- Challenge prior authorization delays. If your medication is being held up, call your state’s Medicaid office. Many have patient advocates who can help.
- Don’t assume your copay is fair. If your generic drug’s price dropped but your copay didn’t, ask why. You might be overpaying.
The truth is, Medicaid’s generic drug system works better than most people think. It’s not perfect, but it’s one of the few places in U.S. healthcare where cost and access actually align. For low-income families, that’s everything.
What’s Next?
Biosimilars-generic versions of biologic drugs-are starting to enter the market. By 2027, they could save Medicaid another $100 billion a year. And if Congress extends the Medicare drug price negotiation rules to Medicaid, experts estimate an extra $15-20 billion in savings over ten years.
But none of that matters if patients can’t get their meds. The real win isn’t the rebate percentage or the copay number. It’s a mother who can fill her child’s inhaler without choosing between groceries and medicine. That’s what generics do. And that’s why they matter more than ever.
Do Medicaid patients always get the lowest price on generics?
Not always. While Medicaid negotiates bulk rebates that drive down drug prices, individual copays depend on state rules. Some states have fixed copays that don’t reflect recent price drops. In 2023, some patients paid $10 for a generic that cost the pharmacy only $3. Always ask your pharmacist if the price can be lowered.
Can I switch from a brand-name drug to a generic on Medicaid?
Yes, and in most cases, you don’t need to do anything. Pharmacies are required to substitute generics unless the prescribing doctor writes "dispense as written" or "no substitution." If you’re unsure, ask your pharmacist. They can check if a generic is available and if your state allows automatic substitution.
Why do some generics still cost so much under Medicaid?
Some generics, especially older ones with little competition, aren’t priced as low as they could be. Also, Pharmacy Benefit Managers (PBMs) often take large fees-up to 31% in some cases-before the drug reaches the pharmacy. These fees don’t always get passed on to patients, so even if the wholesale price drops, your copay might not.
Are there any drugs Medicaid won’t cover as a generic?
Medicaid must cover all medically necessary drugs, including brand-name ones if a generic isn’t available or isn’t appropriate. But if a generic exists and is equally effective, Medicaid will usually require you to use it first. Some states have exceptions for certain conditions, like epilepsy or mental health disorders, where brand-name drugs are preferred.
How does Medicaid’s generic drug pricing compare to private insurance?
Medicaid gets better prices than most private insurers because of its mandatory rebate system. In 2023, Medicaid rebates covered 61% of gross spending in fee-for-service plans. Private insurers don’t have that leverage. Even with pharmacy discount programs, private patients often pay more out of pocket for the same generic drug than Medicaid beneficiaries do.
Can I use a discount drug program like GoodRx instead of Medicaid?
You can, but it’s usually not worth it. Medicaid’s negotiated prices are already among the lowest available. A 2023 study found that for most generic drugs, GoodRx prices were only slightly lower than Medicaid copays-and sometimes higher. Plus, using GoodRx means you’re not using your Medicaid coverage, which could affect your benefits or future eligibility.
Darren Ramowski
My name is Calem Goodridge, and I am a pharmaceutical expert with a passion for educating others about medication and diseases. I have dedicated my career to researching and developing life-changing medical treatments. In my spare time, I enjoy writing articles and sharing my knowledge with the general public to help them make informed healthcare decisions. I am also an advocate for safe medication practices and believe that patient education is key to preventing adverse drug events. With my extensive experience in the pharmaceutical industry, I strive to make a positive impact on the lives of others through my writing.